COVID-19 antiviral treatments research

Get involved in the PANORAMIC trial if you have symptoms of COVID-19 and a positive PCR or lateral flow test. 

Spiky blue sphere representing a virus, surrounded by yellow Y-shaped antibodies

The PANORAMIC trial aims to find out if new antiviral treatments like molnupiravir help those with COVID-19 get better quicker and without needing to be treated in hospital.

The study is open to people aged 50 and over, or aged 18 and over with a health condition that puts them at high risk of getting seriously ill from COVID-19, who have tested positive for COVID-19, and have symptoms that started in the last 5 days. 

No face-to-face visits are required; you can take part from your home anywhere in the UK.

For more information and to sign up to the trial, visit

Published: 17 February 2022